Teprotumumab and Thyroid Eye Disease
Dec 31, 2021•30 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drs. Alison Watson and Seanna Grob review recent data on teprotumumab, the only FDA-approved therapy for thyroid eye disease.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
For the best experience, listen in Metacast app for iOS or Android